Lyra Therapeutics
(OTC) LYRA
Lyra Therapeutics Financials at a Glance
Market Cap
$1.15M
Revenue (TTM)
$398.00K
Net Income (TTM)
$28.92M
EPS (TTM)
$-19.31
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
-0.06 (Low)
Dividend
$0.00
Beta (Volatility)
-0.06 (Low)
Price
$0.65
Volume
23,947
Open
$0.53
Price
$0.65
Volume
23,947
Open
$0.53
Previous Close
$0.65
Daily Range
$0.53 - $0.65
52-Week Range
$0.31 - $37.50
Dividend
$0.00
Beta (Volatility)
-0.06 (Low)
Price
$0.65
Volume
23,947
Open
$0.53
Previous Close
$0.65
Daily Range
$0.53 - $0.65
52-Week Range
$0.31 - $37.50
LYRA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lyra Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
27
CEO
Maria Palasis, PhD
Website
www.lyratherapeutics.comHeadquarters
Watertown, MA 02472, US
LYRA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
-78%
Net Income Margin
-73%
Return on Equity
-6595%
Return on Capital
-1%
Return on Assets
-80%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.15M
Shares Outstanding
1.77M
Volume
23.95K
Short Interest
0.00%
Avg. Volume
100.24K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$31.02M
EBITDA
$31.02M
Operating Cash Flow
$28.86M
Capital Expenditure
$116.00K
Free Cash Flow
$28.98M
Cash & ST Invst.
$15.89M
Total Debt
$30.26M
Lyra Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.00K
-96.7%
Gross Profit
$91.00K
-143.5%
Gross Margin
-13.00%
N/A
Market Cap
$1.15M
N/A
Market Cap/Employee
$38.46K
N/A
Employees
30
N/A
Net Income
$6.95M
+36.7%
EBITDA
$10.08M
-4.8%
Quarterly Fundamentals
Net Cash
$14.37M
-331.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$25.44M
-15.9%
Short Term Debt
$4.82M
+16.9%
Return on Assets
-80.09%
N/A
Return on Invested Capital
-1.17%
N/A
Free Cash Flow
$6.16M
+45.4%
Operating Cash Flow
$6.07M
+46.6%